UK Scleroderma Group: how can treatment of systemic sclerosis be improved?

P. Amlot, P. Bacon, J. J. F. Belch, C. M. Black, R. M. du Bois, D. Briggs, C. P. Denton, A. Gough, A. Herrick, M. I. V. Jayson, A. MacGregor, K. MacRae, N. McHugh, P. Maddison, M. Pugh, A. J. Silman, D. Veale, T. Wallington, K. I. Welsh

    Research output: Contribution to journalComment/debate

    10 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)294
    Number of pages1
    JournalBritish Medical Journal
    Volume317
    Issue number7154
    DOIs
    Publication statusPublished - 1998

    Cite this

    Amlot, P., Bacon, P., Belch, J. J. F., Black, C. M., du Bois, R. M., Briggs, D., Denton, C. P., Gough, A., Herrick, A., Jayson, M. I. V., MacGregor, A., MacRae, K., McHugh, N., Maddison, P., Pugh, M., Silman, A. J., Veale, D., Wallington, T., & Welsh, K. I. (1998). UK Scleroderma Group: how can treatment of systemic sclerosis be improved? British Medical Journal, 317(7154), 294. https://doi.org/10.1136/bmj.317.7154.294